3 Market-Beating Stocks Worth Your Attention

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

The bottom line is that over the long term, earnings growth goes hand in hand with the biggest winners. Keeping that in mind, here are three market-beating stocks that could turbocharge your returns.

Royal Caribbean (RCL)

Five-Year Return: +236%

Established in 1968, Royal Caribbean Cruises (NYSE:RCL) is a global cruise vacation company renowned for its innovative and exciting cruise experiences.

Why Do We Like RCL?

1. Impressive 30% annual revenue growth over the last five years indicates it’s winning market share
2. Free cash flow margin is expected to increase by 11.3 percentage points next year, suggesting the company will have more capital to invest or return to shareholders
3. Returns on capital are increasing as management’s prior bets are starting to bear fruit

At $253.01 per share, Royal Caribbean trades at 14.8x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free for active Edge members.

CECO Environmental (CECO)

Five-Year Return: +577%

With roots dating back to 1869 and a focus on creating cleaner industrial operations, CECO Environmental (NASDAQ:CECO) provides technology and expertise that helps industrial companies reduce emissions, treat water, and improve energy efficiency across various sectors.

Why Is CECO a Good Business?

1. Annual revenue growth of 19% over the last two years was superb and indicates its market share increased during this cycle
2. Expected revenue growth of 17.9% for the next year suggests its market share will rise
3. Adjusted operating margin improvement of 11.4 percentage points over the last five years demonstrates its ability to scale efficiently

CECO Environmental is trading at $49.46 per share, or 37.9x forward P/E. Is now the time to initiate a position? See for yourself in our full research report, it’s free for active Edge members.

United Therapeutics (UTHR)

Five-Year Return: +230%

Founded by a mother seeking treatment for her daughter's pulmonary arterial hypertension, United Therapeutics (NASDAQ:UTHR) develops and commercializes medications for chronic lung diseases and other life-threatening conditions, with a focus on pulmonary hypertension treatments.

Why Are We Bullish on UTHR?

1. Annual revenue growth of 19.1% over the past two years was outstanding, reflecting market share gains this cycle
2. Strong free cash flow margin of 34.9% enables it to reinvest or return capital consistently, and its rising cash conversion increases its margin of safety
3. Returns on capital are growing as management capitalizes on its market opportunities

United Therapeutics’s stock price of $465 implies a valuation ratio of 15.6x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free for active Edge members.

Stocks We Like Even More

The market’s up big this year - but there’s a catch. Just 4 stocks account for half the S&P 500’s entire gain. That kind of concentration makes investors nervous, and for good reason. While everyone piles into the same crowded names, smart investors are hunting quality where no one’s looking - and paying a fraction of the price. Check out the high-quality names we’ve flagged in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.